Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.878%)
Open: 42.00
High: 42.00
Low: 42.00
Prev. Close: 42.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Omega disputes repayment; BWA applies for licenses

Fri, 10th Dec 2021 15:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Omega Diagnostics Group PLC - Alva, Scotland-based medical diagnostics company - Disagrees with request from the Department of Health & Social Care to repay pre-production payment of GBP2.5 million. The amount was originally paid as part of a contract inked in February this year, to provide the DHSC with manufacturing capacity for Covid-19 lateral flow antigen tests. However the DHSC was unable to move into phase 2 of the contract, which would have seen Omega progress to manufacturing tests using government-furnished equipment. Omega says it will continue to take further legal advice on the matter and hopes to reach a resolution swiftly.

Colin King, chief executive of Omega says: "It is clearly disappointing to receive this request for repayment given the efforts we have gone to ensure manufacturing capacity for Covid-19 lateral flow test was available for the DHSC and that we did not progress to Phase 2 of the contract due to the lack of confirmation from the DHSC regarding which test they require us to manufacture."

----------

Standard Life Investments Property Income Trust PLC - property investor - Completes purchase of two properties for GBP22.8 million total. The first is a property in St Helens, where Standard will fund the development of an industrial unit with a total commitment of GBP15.1 million. The second is an existing industrial unit in Washington let to Griffith Textile Machines until September 2035. The purchase price of GBP7.7 million reflects a net initial yield of 5.75%, company says. Both acquisitions are financed out of existing cash reserves.

----------

BWA Group PLC - London-based minerals exploration investment company focussed on Cameroon and Canada - Applies for two rutile sands exploration licences at Song-Loulou in Cameroon. The two areas, comprising a total of 992 square kilometres, are next to the firm's existing licence area at Nkoteng and are part of the same prospective river system. The application has been acknowledged by the Cameroon Ministry of Mines, Investment and Technological Development. BWA now has two exploration licences in Cameroon on which it is already working and is awaiting the issue of a total of five more rutile sands licences.

----------

Kenmare Resources PLC - lithium and zircon producer in Mozambique - Launches tender offer to raise GBP61.8 million. A total of 18.2 million shares are tendered by shareholders under the offer, with 14.8 million shares purchased at a price of GBP4.17 each.

----------

Starcrest Education Ltd - Cayman Islands-based developer and operator of education services - Cancels planned purchase of educational training and apprenticeships specialist National Training Company. Starcrest blamed market conditions for the deal falling through. In August, Starcrest outlined plans to buy the group through a reverse takeover, meaning its shares have remained suspended since then. Following the company's decision, trading in Starcrest's shares will begin again from Friday.

----------

DeepVerge PLC - York, England-based environmental & life science AI company - Completes development of the Microtox PD Covid detection system. Deepverge claims the product is able to detects SARS-CoV-2 and a range of pathogens at local, regional and national levels. The pandemic surveillance units will be launched in the first quarter of 2022.

Chief Executive Gerry Brandon comments: "Size, cost, reach and route to market have been heavily thought through with our new third generation designs. The units are now smaller - allowing them to be installed for smaller populations; mobile - allowing them to be taken to where populations gather; mass producible - allowing more affordability for customers; and just as importantly, available for new partner opportunities."

----------

LSL Property Services PLC - Newcastle-based estate agency - On Thursday, joint venture company Pivotal Growth completes purchase of Glasgow-based mortgage broker Lifetime Finance, marking its first acquisition. Pivotal Growth was established in April 2021 as a joint venture with Pollen Street Capital, with the aim to "buy and build" a leading national mortgage broker. It is planned that at least GBP200 million will be made available through equity and debt to fund acquisitions for Pivotal Growth.

"The Pivotal Growth management team is in active discussion with a number of other brokers that it believes would benefit considerably by being part of Pivotal Growth and we expect to confirm further deals in the early part of 2022," says LSL Chief Executive David Stewart.

----------

Cordel Group PLC - London-based artificial intelligence platform for transport corridor analytics, formerly called Maestrano - On Thursday notes expansion of contract with railroad customer in the US. Original contract saw Cordel's specialist rail analytics subsidiary, Cordel Technology, engineer the data capture process and artificial intelligence analysis of digital point clouds. Customer has now expanded the scope for data capture and analysis to up to 4,500 miles of track.

"We are excited to be moving forward with this expanded Pilot. The USA represents our largest growth opportunity and will provide a meaningful contribution to the group's performance in 2022," comments Chief Executive Nick Smith.

----------

Cambridge Cognition Holdings PLC - Cambridge, England-based digital neuroscience company - On Thursday wins GBP1.0 million schizophrenia clinical trial contract. Revenue from the contract is expected over the next three years. Cambridge Cognition will provide proprietary cognitive assessments and specialist, study management services as part of the agreement. The contract is a repeat purchase from an existing client that has contracted for several other clinical trials for schizophrenia. Chief Executive Matthew Stork states: "We are delighted to have formed an enduring partnership with this pharmaceutical company that recognises the potential for our sensitive cognitive assessments to be used in pivotal clinical trials. This continues to be an exciting area for potential further growth for the company in the future."

----------

Miton Global Opportunities PLC - investor in closed-end investment funds on London Stock Exchange - Changes name to MIGO Opportunities Trust in order to make it easier for potential investors to find and identify the company and to "promote its success in the interests of all shareholders".

----------

Tectonic Gold PLC - Sydney-based exploration company - Announces recent drilling campaign completed 75% of planned program but was cut short due to weather. Able to extract enough data with confirmed gold intersections to advance geological modelling. Now in discussions with potential partners and preparing drilling plans for 2022 and 2023. States the company is fully funded to return to the field and complete final drilling.

----------

By Will Paige; willpaige@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
25 Oct 2019 15:22

Cambridge Cognition hoping to ride coat-tails of Biogen Alzheimer's programme

(Sharecast News) - Cambridge Cognition announced on Friday that, Following a consultation with the US Food and Drug Administration (FDA), Biogen and Eisai have announced plans to pursue regulatory approval for 'aducanumab', which would be the first therapy to tackle clinical decline in early Alzheimer's disease.

Read more
25 Oct 2019 10:37

Cambridge Cognition Senses Opportunity In Biogen's Alzheimer Drug Push

Cambridge Cognition Senses Opportunity In Biogen's Alzheimer Drug Push

Read more
26 Sep 2019 16:33

DIRECTOR DEALINGS: Cambridge Cognition Boss Matthew Stork Buys Shares

DIRECTOR DEALINGS: Cambridge Cognition Boss Matthew Stork Buys Shares

Read more
23 Sep 2019 17:13

DIRECTOR DEALINGS: Cambridge Cognition Non-Executive Chair Buys Shares

DIRECTOR DEALINGS: Cambridge Cognition Non-Executive Chair Buys Shares

Read more
19 Sep 2019 11:52

Cambridge Cognition Interim Revenue Falls As Clinical Trial Sales Lag

(Alliance News) - Neuroscience technology company Cambridge Cognition Holdings PLC on Thursday reported a fall in interim revenue in line with previous guidance that sales were lower than the six

Read more
12 Sep 2019 16:21

UK Earnings, Trading Statements Calendar - Next 7 Days

Friday 13 September  JD WetherspoonFull Year ResultsSthreeQ3 Enterprise Investment

Read more
27 Aug 2019 10:28

WINNERS & LOSERS SUMMARY: Carpetright Up After Shareholder Helps Out

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - LOSERS----------Ferguson,

Read more
27 Aug 2019 09:35

Cambridge Cognition Shares Plunge 40% On Increased Loss Guidance

(Alliance News) - Shares in Cambridge Cognition Holdings PLC collapsed Tuesday after the company said it expects to report its loss widened in the first half due to "difficult" trading a

Read more
27 Aug 2019 09:17

Cambridge Cognition shares tumble after profit warning

(Sharecast News) - Digital solutions developer Cambridge Cognition warned on Tuesday that interim losses looked set to widen after revenues dwindled and costs grew in the six months ended 30 June.

Read more
19 Jul 2019 10:37

Cambridge Cognition Inks NeuroVocalix Deal With Pharma Firm

(Alliance News) - Neuroscience technology company Cambridge Cognition Holdings PLC said it has secured a second commercial partnership with an undisclosed pharmaceutical company for its in the at

Read more
1 Jul 2019 15:48

Cambridge Cognition Names Vertual Boss Debra Leeves As Non-Executive

(Alliance News) - Cambridge Cognition Holdings PLC on Monday said it appointed Debra Leeves as a non-executive director with immediate effect.The neuroscience technology company said Leeves

Read more
25 Apr 2019 14:13

Cambridge Cognition To Shuffle Leadership Team At AGM

LONDON (Alliance News) - Neuroscience firm Cambridge Cognition Holdings PLC on Thursday announced a change of leadership at its upcoming annual general meeting.Cambridge Cognition's be

Read more
19 Mar 2019 11:20

Cambridge Cognition wins biggest digital health contract to date

(Sharecast News) - Neuroscience technology company Cambridge Cognition Holdings announced a "significant" new contract on Tuesday, providing its digital health technologies to a major pharmaceutical company for application in a clinical stage development programme.

Read more
14 Mar 2019 14:03

Lombard Odier Asset Management Holds 5.8% Cambridge Cognition Stake (ALLISS)

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that Lombard Odier Asset Management Europe Ltd holds a 5.75% stake in the cognitive assessment software firm after a on the

Read more
7 Mar 2019 12:32

Cambridge Cognition slips as low order intake sends loss deeper

(Sharecast News) - Cambridge Cognition's shares slipped on Thursday after it reported that low order intake from 2017 had caused its annual losses to widen and revenues to fall.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.